Investigation of healthcare infection risks from water-related organisms: Summary of CDC consultations, 2014-2017.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 4 4 2019
medline: 10 4 2020
entrez: 4 4 2019
Statut: ppublish

Résumé

Water exposures in healthcare settings and during healthcare delivery can place patients at risk for infection with water-related organisms and can potentially lead to outbreaks. We aimed to describe Centers for Disease Control and Prevention (CDC) consultations involving water-related organisms leading to healthcare-associated infections (HAIs). Retrospective observational study. We reviewed internal CDC records from January 1, 2014, through December 31, 2017, using water-related terms and organisms, excluding Legionella, to identify consultations that involved potential or confirmed transmission of water-related organisms in healthcare. We determined plausible exposure pathways and routes of transmission when possible. Of 620 consultations during the study period, we identified 134 consultations (21.6%), with 1,380 patients, that involved the investigation of potential water-related HAIs or infection control lapses with the potential for water-related HAIs. Nontuberculous mycobacteria were involved in the greatest number of investigations (n = 40, 29.9%). Most frequently, investigations involved medical products (n = 48, 35.8%), and most of these products were medical devices (n = 40, 83.3%). We identified a variety of plausible water-exposure pathways, including medication preparation near water splash zones and water contamination at the manufacturing sites of medications and medical devices. Water-related investigations represent a substantial proportion of CDC HAI consultations and likely represent only a fraction of all water-related HAI investigations and outbreaks occurring in US healthcare facilities. Water-related HAI investigations should consider all potential pathways of water exposure. Finally, healthcare facilities should develop and implement water management programs to limit the growth and spread of water-related organisms.

Identifiants

pubmed: 30942147
pii: S0899823X19000606
doi: 10.1017/ice.2019.60
pmc: PMC7883772
mid: NIHMS1669733
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-626

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Références

Environ Health Perspect. 2015 Aug;123(8):749-58
pubmed: 25793551
Curr Opin Infect Dis. 2013 Aug;26(4):345-51
pubmed: 23806897
Pediatrics. 2007 Jun;119(6):1061-8
pubmed: 17545371
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):854-857
pubmed: 30091968
MMWR Morb Mortal Wkly Rep. 2016 Oct 14;65(40):1117-1118
pubmed: 27740609
Biofouling. 2013;29(2):147-62
pubmed: 23327332
PLoS One. 2013;8(3):e59015
pubmed: 23536849
Euro Surveill. 2016 Apr 28;21(17):
pubmed: 27168588
Am J Infect Control. 2018 Jun;46(6):649-655
pubmed: 29329922
Clin Infect Dis. 2017 Apr 1;64(7):912-913
pubmed: 28082270
J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e116-e122
pubmed: 28903524
Arch Intern Med. 2005 Dec 12-26;165(22):2565-7
pubmed: 16344410
Clin Infect Dis. 2017 May 15;64(10):1435-1444
pubmed: 28200000
MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1216-1221
pubmed: 29121003
MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1177
pubmed: 26492452
Ann Am Thorac Soc. 2017 Mar;14(3):314-317
pubmed: 27997817
Clin Infect Dis. 2019 Jul 18;69(3):445-449
pubmed: 30346502
Int J Hyg Environ Health. 2017 May;220(3):611-620
pubmed: 28017547
Infect Control Hosp Epidemiol. 2018 Aug;39(8):972-979
pubmed: 29950189
MMWR Morb Mortal Wkly Rep. 2016 Apr 08;65(13):355-6
pubmed: 27054966
Curr Opin Infect Dis. 2017 Aug;30(4):388-394
pubmed: 28538044
MMWR Morb Mortal Wkly Rep. 2017 Jun 09;66(22):584-589
pubmed: 28594788
Euro Surveill. 2013 May 02;18(18):20471
pubmed: 23725776
Clin Infect Dis. 2016 Jun 1;62(11):1423-35
pubmed: 26936670
Clin Infect Dis. 2017 Aug 15;65(4):669-674
pubmed: 28430899

Auteurs

Kiran M Perkins (KM)

Division of Healthcare Quality Promotion,Centers for Disease Control and Prevention,Atlanta, Georgia.

Sujan C Reddy (SC)

Division of Healthcare Quality Promotion,Centers for Disease Control and Prevention,Atlanta, Georgia.

Ryan Fagan (R)

Division of Healthcare Quality Promotion,Centers for Disease Control and Prevention,Atlanta, Georgia.

Matthew J Arduino (MJ)

Division of Healthcare Quality Promotion,Centers for Disease Control and Prevention,Atlanta, Georgia.

Joseph F Perz (JF)

Division of Healthcare Quality Promotion,Centers for Disease Control and Prevention,Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH